Clinical trial
Long-Term Follow-Up Study of Psoriasis Patients
NCT00131066 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00131066 |
|---|---|
| Title | Long-Term Follow-Up Study of Psoriasis Patients |
| Official title | Long-Term Safety Follow-Up Study of Psoriasis Patients Who Have Received MEDI-507 |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Psoriasis |
| Intervention type | Other |
| Interventions | Follow up from previous treatment with MEDI-507 |
| Enrollment | 200 |
| Start date | Aug 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Dec 1, 2007 |
| First posted | Aug 17, 2005 |
| Last update posted | Sep 22, 2008 |
| Countries | Belgium, Canada, France, Germany, Netherlands, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: